• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性肾损伤的重症患者:临床决定因素与尸检组织学

Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology.

作者信息

Gleeson Patrick James, Crippa Ilaria Alice, Sannier Aurélie, Koopmansch Caroline, Bienfait Lucie, Allard Justine, Sexton Donal J, Fontana Vito, Rorive Sandrine, Vincent Jean-Louis, Creteur Jacques, Taccone Fabio Silvio

机构信息

Department of Intensive Care Medicine, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Université de Paris Cité, INSERM UMR1149 & CNRS EMR8252, Centre de Recherche sur l'Inflammation, Inflamex Laboratory of Excellence, Paris, France.

出版信息

Clin Kidney J. 2023 May 22;16(10):1664-1673. doi: 10.1093/ckj/sfad113. eCollection 2023 Oct.

DOI:10.1093/ckj/sfad113
PMID:37779855
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10539222/
Abstract

BACKGROUND

Acute kidney injury (AKI) requiring renal replacement therapy (RRT) in the intensive care unit (ICU) portends a poor prognosis. We aimed to better characterize predictors of survival and the mechanism of kidney failure in these patients.

METHODS

This was a retrospective observational study using clinical and radiological electronic health records, analysed by univariable and multivariable binary logistic regression. Histopathological examination of post-mortem renal tissue was performed.

RESULTS

Among 157 patients with AKI requiring RRT, higher serum creatinine at RRT initiation associated with increased ICU survival [odds ratio (OR) 0.33, 95% confidence interval (CI) 0.17-0.62,  = .001]; however, muscle mass (a marker of frailty) interacted with creatinine ( = .02) and superseded creatinine as a predictor of survival (OR 0.26, 95% CI 0.08-0.82;  = .02). Achieving lower cumulative fluid balance (mL/kg) predicted ICU survival (OR 1.01, 95% CI 1.00-1.01,  < .001), as supported by sensitivity analyses showing improved ICU survival with the use of furosemide (OR 0.40, 95% CI 0.18-0.87,  = .02) and increasing net ultrafiltration (OR 0.97, 95% CI 0.95-0.99,  = .02). A urine output of >500 mL/24 h strongly predicted successful liberation from RRT (OR 0.125, 95% CI 0.05-0.35,  < .001). Post-mortem reports were available for 32 patients; clinically unrecognized renal findings were described in 6 patients, 1 of whom had interstitial nephritis. Experimental staining of renal tissue from patients with sepsis-associated AKI (S-AKI) showed glomerular loss of synaptopodin ( = .02).

CONCLUSIONS

Confounding of creatinine by muscle mass undermines its use as a marker of AKI severity in clinical studies. Volume management and urine output are key determinants of outcome. Loss of synaptopodin implicates glomerular injury in the pathogenesis of S-AKI.

摘要

背景

在重症监护病房(ICU)中,需要肾脏替代治疗(RRT)的急性肾损伤(AKI)预示着预后不良。我们旨在更好地描述这些患者生存的预测因素及肾衰竭的机制。

方法

这是一项回顾性观察性研究,使用临床和放射学电子健康记录,通过单变量和多变量二元逻辑回归进行分析。对尸检肾组织进行组织病理学检查。

结果

在157例需要RRT的AKI患者中,RRT开始时较高的血清肌酐水平与ICU生存率增加相关[比值比(OR)0.33,95%置信区间(CI)0.17 - 0.62,P = 0.001];然而,肌肉量(衰弱的一个标志物)与肌酐存在相互作用(P = 0.02),并取代肌酐成为生存的预测因素(OR 0.26,95%CI 0.08 - 0.82;P = 0.02)。实现更低的累积液体平衡(mL/kg)可预测ICU生存(OR 1.01,95%CI 1.00 - 1.01,P < 0.001),敏感性分析支持这一点,该分析显示使用呋塞米可改善ICU生存(OR 0.40,95%CI 0.18 - 0.87,P = 0.02)以及增加净超滤量(OR 0.97,95%CI 0.95 - 0.99,P = 0.02)。尿量>500 mL/24 h强烈预测RRT成功脱机(OR 0.125,95%CI 0.05 - 0.35,P < 0.001)。32例患者有尸检报告;6例患者描述了临床上未识别的肾脏发现,其中1例患有间质性肾炎。脓毒症相关AKI(S - AKI)患者肾组织的实验性染色显示突触素在肾小球丢失(P = 0.02)。

结论

肌肉量对肌酐的混淆作用削弱了其在临床研究中作为AKI严重程度标志物的用途。容量管理和尿量是结局的关键决定因素。突触素的丢失提示肾小球损伤在S - AKI发病机制中起作用。

相似文献

1
Critically ill patients with acute kidney injury: clinical determinants and post-mortem histology.急性肾损伤的重症患者:临床决定因素与尸检组织学
Clin Kidney J. 2023 May 22;16(10):1664-1673. doi: 10.1093/ckj/sfad113. eCollection 2023 Oct.
2
Cardiac biomarkers are associated with maximum stage of acute kidney injury in critically ill patients: a prospective analysis.心脏生物标志物与危重症患者急性肾损伤的最大分期相关:一项前瞻性分析。
Crit Care. 2017 Apr 12;21(1):88. doi: 10.1186/s13054-017-1674-5.
3
[Analysis of the characteristics of patients suffering from acute kidney injury following severe trauma receiving renal replacement therapy].[严重创伤后接受肾脏替代治疗的急性肾损伤患者特征分析]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 May;27(5):349-53. doi: 10.3760/cma.j.issn.2095-4352.2015.05.006.
4
[Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].基于KDIGO分类的早期启动连续性肾脏替代治疗对急性肾损伤危重症患者预后的影响
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):246-51.
5
Discontinuation of renal replacement therapy in critically ill patients with severe acute kidney injury: predictive factors of renal function recovery.重症急性肾损伤危重症患者肾脏替代治疗的终止:肾功能恢复的预测因素
Int Urol Nephrol. 2018 Oct;50(10):1845-1851. doi: 10.1007/s11255-018-1947-1. Epub 2018 Aug 2.
6
Comparison of early and delayed strategy for renal replacement therapy initiation for severe acute kidney injury with heart failure: a retrospective comparative cohort study.重度急性肾损伤合并心力衰竭患者肾替代治疗起始的早期与延迟策略比较:一项回顾性比较队列研究
Transl Androl Urol. 2023 May 31;12(5):715-726. doi: 10.21037/tau-23-146. Epub 2023 May 9.
7
Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.危重症患者不良急性肾损伤结局的生物标志物预测因素:都柏林急性生物标志物组评估研究。
Am J Nephrol. 2019;50(1):19-28. doi: 10.1159/000500231. Epub 2019 Jun 14.
8
[Renal echography and cystatin C for prediction of acute kidney injury: very different in patients with cardiac failure or sepsis].[肾脏超声检查和胱抑素C对急性肾损伤的预测:在心力衰竭或脓毒症患者中差异很大]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019 Oct;31(10):1258-1263. doi: 10.3760/cma.j.issn.2095-4352.2019.10.015.
9
Predictive factors for severe long-term chronic kidney disease after acute kidney injury requiring renal replacement therapy in critically ill patients: an ancillary study of the ELVIS randomized controlled trial.预测危重症急性肾损伤患者需要肾脏替代治疗后发生严重长期慢性肾脏病的因素:ELVIS 随机对照试验的辅助研究。
Crit Care. 2022 Nov 29;26(1):367. doi: 10.1186/s13054-022-04233-4.
10
RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit.基于 RIFLE 的数据采集/管理系统应用于一项前瞻性队列多中心意大利研究,旨在调查重症监护病房急性肾损伤的流行病学。
Blood Purif. 2011;31(1-3):159-71. doi: 10.1159/000322161. Epub 2011 Jan 10.

引用本文的文献

1
Hyperlactatemia in critically ill patients with acute kidney injury treated with renal replacement therapy in the intensive care unit.重症监护病房中接受肾脏替代治疗的急性肾损伤重症患者的高乳酸血症
BMC Nephrol. 2025 Apr 30;26(1):217. doi: 10.1186/s12882-025-04149-5.
2
The utility of point-of-care ultrasound in critical care nephrology.床旁超声在危重症肾脏病学中的应用
Front Nephrol. 2024 Oct 3;4:1402641. doi: 10.3389/fneph.2024.1402641. eCollection 2024.
3
Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach.

本文引用的文献

1
The impact of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury on mortality and clinical outcomes: a meta-analysis.急性肾损伤危重症患者早期与晚期开始肾脏替代治疗对死亡率和临床结局的影响:一项荟萃分析。
Clin Kidney J. 2022 May 12;15(10):1932-1945. doi: 10.1093/ckj/sfac139. eCollection 2022 Oct.
2
Predialysis Urea Nitrogen Is a Nutritional Marker of Hemodialysis Patients.透析前尿素氮是血液透析患者的营养标志物。
Chonnam Med J. 2022 May;58(2):69-74. doi: 10.4068/cmj.2022.58.2.69. Epub 2022 May 25.
3
Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial.
连续性肾脏替代治疗中的精准净超滤剂量:一种实用方法
Intensive Care Med Exp. 2023 Nov 28;11(1):83. doi: 10.1186/s40635-023-00566-8.
比较两种延迟策略对严重急性肾损伤(AKIKI 2)患者开始肾脏替代治疗的效果:一项多中心、开放标签、随机、对照试验。
Lancet. 2021 Apr 3;397(10281):1293-1300. doi: 10.1016/S0140-6736(21)00350-0.
4
Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.急性肾损伤中肾脏替代治疗的启动时机。
N Engl J Med. 2020 Jul 16;383(3):240-251. doi: 10.1056/NEJMoa2000741.
5
Frailty in Critical Care Medicine: A Review.危重病医学中的衰弱:综述。
Anesth Analg. 2020 Jun;130(6):1462-1473. doi: 10.1213/ANE.0000000000004665.
6
Association between furosemide administration and outcomes in critically ill patients with acute kidney injury.呋塞米给药与急性肾损伤重症患者结局的关联。
Crit Care. 2020 Mar 4;24(1):75. doi: 10.1186/s13054-020-2798-6.
7
Acute kidney injury.急性肾损伤。
Lancet. 2019 Nov 23;394(10212):1949-1964. doi: 10.1016/S0140-6736(19)32563-2.
8
Impact of furosemide on mortality and the requirement for renal replacement therapy in acute kidney injury: a systematic review and meta-analysis of randomised trials.呋塞米对急性肾损伤患者死亡率及肾脏替代治疗需求的影响:一项随机试验的系统评价和荟萃分析
Ann Intensive Care. 2019 Jul 24;9(1):85. doi: 10.1186/s13613-019-0557-0.
9
Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial.网络超滤率与接受连续性静脉-静脉血液滤过治疗的急性肾损伤危重症成人死亡率的相关性:肾脏替代治疗随机评估正常 vs 增强水平(RENAL)试验的二次分析。
JAMA Netw Open. 2019 Jun 5;2(6):e195418. doi: 10.1001/jamanetworkopen.2019.5418.
10
Frailty assessment: from clinical to radiological tools.虚弱评估:从临床到影像学工具。
Br J Anaesth. 2019 Jul;123(1):37-50. doi: 10.1016/j.bja.2019.03.034. Epub 2019 May 3.